FdaApplication
ANDA 211535
Identifiers
- fda_app_no: ANDA211535
Properties
| Property | Value |
|---|---|
| applicant_name | CIPLA LTD |
| application_type | ANDA |
| approval_date | 2026-04-06 |
Products (2)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| DAPAGLIFLOZIN | DAPAGLIFLOZIN | 10MG | TABLET;ORAL |
| DAPAGLIFLOZIN | DAPAGLIFLOZIN | 5MG | TABLET;ORAL |
2 products